Maarten van der Doelen

Appendices

LD

Lactate dehydrogenase Lactate dehydrogenase

LDH

mCRPC mHSPC

Metastatic castration-resistant prostate cancer Metastatic hormone-sensitive prostate cancer

MRI

Magnetic resonance imaging

NA

Not applicable Sodium fluoride

NaF

NE

Not evaluable/evaluated Next generation sequencing Neutrophil-to-lymphocyte ratio Not reached or Not reported

NGS NLR

NR OS

Overall survival

PARP

Poly (ADP-ribose) polymerase

PCa

Prostate cancer

PCWG

Prostate Cancer Working Group

PERCIST

Positron Emission tomography Response Criteria In Solid Tumors

PET

Position-emission tomography Patient-reported outcome measures

PROMs

PSA

Prostate-specific antigen

PSMA

Prostate-specific membrane antigen

QoL

Quality of life

RECIST

Response Evaluation Criteria In Solid Tumors

RLT

Radioligand therapy Standard deviation Skeletal related event

SD

SRE

SUV max

Maximum standardized uptake value Targeting alpha-radionuclide therapy

TAT

WBC

White blood cell

244